KNW: Instrument, Biopsy
What it covers
A gastroenterology-urology biopsy instrument is a device used to remove, by cutting or aspiration, a specimen of tissue for microscopic examination. This generic type of device includes the biopsy punch, gastrointestinal mechanical biopsy instrument, suction biopsy instrument, gastro-urology biopsy needle and needle set, and nonelectric biopsy forceps. This section does not apply to biopsy instruments that have specialized uses in other medical specialty areas and that are covered by classification regulations in other parts of the device classification regulations.
The identification in 21 CFR 876.1075, gastroenterology-urology biopsy instrument. FDA gives KNW no definition of its own, so the regulation’s describes it.
Recent clearances
| 510(k) | Device | Applicant | Decision | Type |
|---|---|---|---|---|
| K260517 | Automatic Core Biopsy Instrument | Zhejiang Curaway Medical Technology Co., Ltd. | Aug 28, 2026 | Traditional |
| K262571 | EnCor EnCompass Breast Biopsy and Tissue Removal System | Bard Peripheral Vascular, Inc. | Aug 14, 2026 | Special |
| K262792 | Brevera Biopsy System with CorLumina Imaging Technology (BREVDISP09) | Hologic, Inc. | Aug 12, 2026 | Special |
| K260572 | Marrow Marxman | Medimetrix, LLC | Aug 4, 2026 | Traditional |
| K261196 | Promisemed VeriEcto Automatic Biopsy Needles | Promisemed Hangzhou Meditech Co., Ltd. | May 12, 2026 | Special |
| K260365 | Mammotome Prima MR Dual Vacuum-Assisted Breast Biopsy System Control Module; Mammotome Prima MR Dual Vacuum-Assisted Breast Biopsy System Disposable Probe, 8 gauge; Mammotome Prima MR Dual Vacuum-Assisted Breast Biopsy System Disposable Targeting Set, 8 gauge; Mammotome Prima MR Dual Vacuum-Assisted Breast Biopsy System Foot Switch; Mammotome Prima MR Dual Vacuum-Assisted Breast Biopsy System Reusable Tray; Mammotome Prima MR Dual Vacuum-Assisted Breast Biopsy System Battery Char | Devicor Medical Products, Inc. | Mar 4, 2026 | Traditional |
| K252795 | ZeniCore Automatic Biopsy Instrument (863212100 / ZeniCore Automatic Biopsy Device 12ga x 10cm with Coaxial Introducer Kit); ZeniCore Automatic Biopsy Instrument (863212130 / ZeniCore Automatic Biopsy Device 12ga x 13cm with Coaxial Introducer Kit); ZeniCore Automatic Biopsy Instrument (863214100 / ZeniCore Automatic Biopsy Device 14ga x 10cm with Coaxial Introducer Kit); ZeniCore Automatic Biopsy Instrument (863214130 / ZeniCore Automatic Biopsy Device 14ga x 13cm with Coaxial | Argon Medical Devices, Inc. | Feb 23, 2026 | Traditional |
| K252681 | EnCor EnCompass Breast Biopsy and Tissue Removal System | Bard Peripheral Vascular, Inc. | Dec 12, 2025 | Traditional |
| K252183 | Resitu Slider 09 (RESL09) | Resitu Medical AB | Sep 24, 2025 | Traditional |
| K243407 | Forcyte Autograft Harvest Kit | Forcyte Medical, LLC | Jul 29, 2025 | Traditional |
Clearances by year
123 KNW 510(k)s were cleared from 2011 to Oct 29, 2026. Days to decision run from the day FDA received the 510(k) to its decision, including time on hold.
| Year | Clearances | Median days to decision |
|---|---|---|
| 2026 (so far) | 7 | 29 |
| 2025 | 12 | 178 |
| 2024 | 5 | 114 |
| 2023 | 7 | 164 |
| 2022 | 8 | 203 |
| 2021 | 9 | 54 |
| 2020 | 8 | 92 |
| 2019 | 5 | 94 |
| 2018 | 7 | 71 |
| 2017 | 8 | 90 |
| 2016 | 9 | 127 |
| 2015 | 10 | 106 |
| 2014 | 8 | 95 |
| 2013 | 3 | 100 |
| 2012 | 7 | 94 |
| 2011 | 10 | 64 |
Who submits
71 applicants cleared a KNW device since 2011. 71% of the clearances went to applicants in United States, then China (11%), Italy (7%) and Sweden (4%). By type: Traditional 80% and Special 20%. 6 went through a third-party review organization.
| Applicant | Clearances since 2011 |
|---|---|
| Devicor Medical Products, Inc. | 7 |
| Bard Peripheral Vascular, Inc. | 6 |
| Medax Srl Unipersonale | 5 |
| Hologic, Inc. | 4 |
| Ranfac Corporation | 4 |
| Stryker Corporation | 4 |
| Zhejiang Curaway Medical Technology Co., Ltd. | 4 |
| Avitus Orthopaedics, Inc. | 3 |
How FDA classifies it
(1) Class II (performance standards).
(2) Class I for the biopsy forceps cover and the non-electric biopsy forceps. The devices subject to this paragraph (b)(2) are exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 876.9.
From 21 CFR 876.1075. Special controls are the requirements a 510(k) must show it meets.
Standards
21 CFR 876.1075 names no consensus standards. Check FDA’s recognized standards database, or ask which standards recent KNW clearances declared.
Ask about KNW
Questions about KNW
What is FDA product code KNW?
Product code KNW, “Instrument, Biopsy” in FDA's classification database, is a Class II device type under 21 CFR 876.1075 (gastroenterology-urology biopsy instrument), reviewed by FDA's Gastroenterology, Urology panel. FDA's 510(k) database lists 365 clearances under KNW, 123 of them since 2011.
How many 510(k) clearances are there under KNW?
FDA’s 510(k) database listed 365 clearances under KNW as of Oct 29, 2026, 123 of them decided since 2011; the most recent decision was Aug 28, 2026. The Predicate Finder searches the live database.
How long does FDA take to clear a KNW 510(k)?
For the 20 KNW clearances decided in the two years before Oct 29, 2026, the median time from FDA receiving the 510(k) to its decision was 165 days. That counts calendar days, including time the submission was on hold waiting for answers from the submitter.
Which companies have the most KNW clearances?
Since 2011: Devicor Medical Products, Inc. (7), Bard Peripheral Vascular, Inc. (6), Medax Srl Unipersonale (5), Hologic, Inc. (4) and Ranfac Corporation (4). 71 applicants have cleared a KNW device in that time.